Table 1. Participating countries for which GLaMOR estimated all-cause, cardiorespiratory, or respiratory pandemic-associated mortality (Stage 1) or which were used to evaluate performance of global projection methods (Stage 2).

WHO Region (Number of Countries)	Country	Income Levela	Data Years	Outcomeb	Detailc	Virology Source	Percent World Population
Countries for which GLaMOR made all-cause, cardiorespiratory, or respiratory Stage 1 estimates
Africa (1)	South Africa	Upper middle	2003–2009	AC,CR,R	Monthly	FluNet	0.7
Eastern Mediterranean (0)
Europe (9)	Denmark	High	1998–2009	AC	Weekly	FluNet	0.1
	Israel	High	2004–2009	AC,CR,Rd	Weekly	Israel	0.1
	France	High	1998–2009	AC,CR,R	Weekly	FluNet	0.9
	Germany	High	1998–2009	AC,CR,R	Weekly	Germany	1.3
	Poland	Upper middle	2003–2009	AC,CR,R	Weekly	FluNet	0.4
	Romania	Upper middle	2005–2009	AC,CR,R	Weekly	EuroFlu	0.3
	Slovenia	High	2003–2009	AC,CR,R	Weekly	FluNet	0.1
	Spain	High	2000–2009	AC,CR,R	Weekly	Spain	0.7
	UK	High	2000–2009	AC,CR,R	Weekly	UK	0.9
Americas (4)	Argentina	Upper middle	2001–2009	AC,CR,R	Monthly	FluNet	0.6
	Chile	Upper middle	2002–2009	AC,CR,R	Weekly	FluNet	0.2
	Mexico	Upper middle	2000–2009	AC,CR,R	Weekly	FluNet	1.6
	US	High	2000–2009	AC,CR,R	Weekly	FluNet	4.6
South-East Asia (0)
Western Pacific (7)	Australia	High	2003–2009	AC,CR,R	Weekly	FluNet	0.3
	Chinae	Lower middle	2004–2009	AC,CR,R	Weekly	China	19.5
	Hong Kong	High	1999–2009	AC,CR,R	Weekly	Hong Kong	0.1
	Japan	High	1998–2009	AC,CR,R	Weekly	FluNet	1.9
	New Zealand	High	2000–2009	AC,CR,R	Weekly	FluNet	0.1
	Republic of Korea	High	2003–2009	CR,R	Weekly	FluNet	0.7
	Singapore	High	2007–2009	CR,R	Weekly	Singapore, FluNet	0.1
Validation countries to evaluate performance of Stage 2 projection methods
Americas (3)	Brazil	Upper middle	NA	R	Weekly	NA	2.8
	Canada	High	NA	R	Weekly	Canada	0.5
	Peru	Upper middle	NA	R	Monthly	Peru	0.4
Europe (1)	Netherlandsf	High	NA	R	Weekly	Netherlands	0.2
South-East Asia (1)	Bangladeshg	Low	NA	R	NA	Bangladesh	2.1

^aIncome level in 2009 [28].

^bUnderlying cause of mortality: AC, all cause; CR, cardiorespiratory (ICD-10 I and J codes); R, respiratory (ICD-10 J codes).

^cStandard request was for age groupings: 0–4, 5–14, 15–44, 45–64, 65–84, and ≥85 y of age.

^dDid not include influenza with pneumonia.

^eData from multiple surveillance settings representing rural and urban areas across China [14].

^fRespiratory mortality estimated by Netherlands team based on estimated all-cause pandemic mortality [13].

^gRespiratory mortality estimated by Bangladesh team using a novel method combining virology surveillance and verbal autopsy data [45].

NA, not available.